Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
6 Months Ended
Oct. 31, 2023
Oct. 31, 2022
Cash flows from operating activities:    
Net loss $ (393,401) $ (3,425,519)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock issued for services 0 2,278
Stock issued for compensation 0 6,667
Stock-based compensation 0 8,807
Change in fair value of warrant liability (2,623,000) 0
Change in fair value of derivative liability 1,299,000 0
Change in assets and liabilities:    
Decrease in prepaid expenses and other current assets (215,508) (162,637)
Increase (decrease) in accounts payable (2,118) 655,916
Increase (decrease) in accrued expenses 293,632 (49,154)
Net cash used in operating activities (1,641,395) (2,963,642)
Cash flows from investing activities:    
Net cash provided by (used in) investing activities 0 0
Cash flows from financing activities:    
Repurchase of common stock (26,622,277) (5,475,891)
Proceeds from issuance of preferred stock, net of transaction costs 33,650,075 0
Proceeds from warrant exercise 70 880
Net cash provided by (used in) financing activities 7,027,868 (5,475,011)
Effect of currency rate exchange on cash and cash equivalents (1,140) 584
Net increase (decrease) in cash and cash equivalents 5,385,333 (8,438,069)
Cash and cash equivalents at beginning of the periods 68,039,936 85,400,656
Cash and cash equivalents at end of the periods 73,425,269 76,962,587
Supplemental disclosure of cash flows information:    
Cash paid during the periods for income taxes 1,600 0
Supplemental disclosure of cash flows information:    
Non-cash derivative liability at initial fair value 2,770,000 0
Non-cash warrant liability at initial fair value 14,127,000 0
Reclassification of Series B Convertible Preferred Stock and dividends to current liability 4,095,271 0
Accretion of discounts to redemption value of Series B Preferred Stock 7,733,130 0
Excise tax accrued on repurchase of common stock $ 266,223